The IPO Buzz: Windward Bio (WWB Proposed) Sets Terms for $175 Million IPO

Windward Bio (WWB Proposed), a Swiss biotech developing long-acting drug candidates to treat asthma, COPD and atopic dermatitis, unveiled the terms early today (Monday, Nov. 9,2026) for its $175 million IPO. Windward Bio is offering 10.29 million shares at a price range of $16.00 to $18.00 to raise $174.93 million, if priced at the $17.00 mid-point of its range, according to its F-1/A filing date..

Read more November 9, 2026

IPO Calendar

Company Symbol proposed Lead Managers Shares (Millions) Price Low Price High Est. $ Volume Expected to Trade SCOOP Rating Rating Change
Rezera Inc. RZRA Jefferies/TD Cowen/Cantor/Wedbush PacGrow 16.7 11.00 13.00 $ 200.0 mil 11/12/2026 Thursday S/O S/O
vVardis Holding VVVV Goldman Sachs/J.P. Morgan/William Blair/UBS Investment Bank/Deutsche Bank, 9.5 21.00 24.00 $ 214.3 mil 11/13/2026 Friday S/O S/O
Windward Bio Group AG WWB Jefferies/TD Cowen/Piper Sandler/UBS Investment Group 10.3 16.00 18.00 $ 174.9 mil 11/13/2026 Friday S/O S/O
Read more

Last 100 IPOs - November 8, 2026

Number of IPOs priced : 100
Number Up: 42
Number Down: 56
Number Unchanged: 2
Percentage Change From Issue Price: -0.01%
Percentage Change for The Nasdaq Composite 35.22%

2026 IPO Scorecard - November 8, 2026

Number of IPOs priced (Excluding 154 units) : 138
Number Up: 53
Number Down: 83
Number Unchanged: 2
Total Return From Issue Price: -1.55%
The Nasdaq Composite Index YTD % Change 35.22%